ReviewFrontiers in immunology2023

Immune checkpoint inhibitors and Chimeric Antigen Receptor (CAR)-T cell therapy: Potential treatment options against Testicular Germ Cell Tumors.

Giuseppe Schepisi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.